Skip to main content
ONTHERICE.org
Search the world…
All SignalsInvestment · Read step by step

OTR EMERGING DATA

Lam Research (LRCX): Missing parts may delay the rebound

Start with the main idea: what may be changing, how the clues connect, and what remains uncertain.

We see a delivery problem, not proof that chip demand has disappeared. Some Lam shipments could move from the December quarter into the March quarter because important parts are tight. Analysts are keeping much of their longer-term earnings outlook while lowering near-term estimates or valuations.

The idea, step by step · OnTheRice’s Emerging Data

Start with the main idea: what may be changing, how the clues connect, and what remains uncertain.

Read the matching explanation in OTR EMERGING DATA.

The key clues · Key points

See the main observations behind the idea, with their important qualifications.

  • We see a fresh market report identify supply-chain constraints as a limit on fiscal Q2 sales, even after adjusted earnings and revenue beat expectations.
  • Investment call details are available with membership.
  • Investment call details are available with membership.
  • We see the repricing spreading beyond one analyst: New Street Research lowered its target to $255 from $285.
  • We see pressure from the customers' funding model: Meta's capital-spending needs and new non-voting share class brought attention to equity funding and dilution across the AI trade.
  • We see a large completed price adjustment: LRCX closed at $230.15, down 11.76%, on 22 October. This reaction may already reflect much of the bad news.
  • We see the selloff reach the wider semiconductor market: the SOX fell 6.7% and the Nasdaq Composite fell 2.6% in the completed 22 October session. This means the Lam move was not purely company-specific.

What could change this view?

See what could change this interpretation and what still needs to be checked.

Demand remains strong and the shortage may be temporary. BofA increased its later earnings estimates.

The stock already fell sharply and then rebounded before the next session; optimistic social sentiment also warns against assuming selling must continue.

Watch for confirmed improvement in component supply and shipment timing.

The eventual delivery of equipment is a separate business test, not something expected to finish within this one-week call.

What this means · Bottom line

Read the takeaway and the limits that matter before drawing a conclusion.

Confidence: 55%, based on judgement, with accuracy not established by testing.

Base research confidence: 57%; social counterweight: -2 percentage points; final confidence: 55%. This is editorial judgment, not measured accuracy or social-post share.

Its source facts and prices still need independent checks.

Evidence behind this view

Review the information supporting this view and the limits on what it can show.

Checks whether separate pieces of evidence support the same view.

Evidence 1: We see a fresh market report identify supply-chain constraints as a limit on fiscal Q2 sales, even after adjusted earnings and revenue beat expectations.

Source: MT Newswires via MarketScreener — Source timestamp or bound: published at utc: 2026-10-22T09:33:00Z; original: 10/22/2026 05:33 am EDT Measurement period: Fiscal quarter ended September 27, 2026; December-quarter guidance; earnings call October 21, 2026.

Verification and access limits: Exact EDT publication time verified on the public MT Newswires headline page. Public headline and exact publication timestamp only; body paywalled.

Detailed analytical claims remain supported separately by the opened full article. Supporting detail:

Source: MT Newswires via MarketScreener — Source timestamp or bound: published at utc: 2026-10-22T13:01:00Z; original: 10/22/2026 09:01 am EDT Measurement period: Analyst action October 22; calendar 2027/2028 estimates.

Supporting detail:

Source: MT Newswires via MarketScreener — Source timestamp or bound: published at utc: 2026-10-22T12:52:00Z; original: 10/22/2026 08:52 am EDT Measurement period: October 22 analyst revision; next-quarter versus calendar 2028 estimates.

Supporting detail:

Evidence 4: We see the repricing spreading beyond one analyst: New Street Research lowered its target to $255 from $285.

Source: MT Newswires via MarketScreener — Source timestamp or bound: published at utc: 2026-10-22T16:11:00Z; original: 10/22/2026 12:11 pm EDT Measurement period: October 22 analyst action.

Verification and access limits: Public title and timestamp opened; body paywalled. No claim from unseen body.

Evidence 5: We see pressure from the customers' funding model: Meta's capital-spending needs and new non-voting share class brought attention to equity funding and dilution across the AI trade.

Source: Reuters via MarketScreener — Source timestamp or bound: published at utc: 2026-10-22T18:57:00Z; updated at utc: 2026-10-22T20:35:00Z; original: 10/22/2026 02:57 pm EDT; modified 04:35 pm EDT Measurement period: October 22 market reaction; Meta's prior-day results and future funding plans.

Verification and access limits: Full article opened.

Evidence 6: We see a large completed price adjustment: LRCX closed at $230.15, down 11.76%, on 22 October.

Source: MarketBeat quote data — Source timestamp or bound: measurement as of utc: 2026-10-22T20:00:00Z; original: Closing price 10/22/2026 04:00 PM Eastern Measurement period: 22 October Nasdaq regular session. Verification and access limits: Full quote opened; close cross-checked with MarketScreener.

Evidence 7: We see the selloff reach the wider semiconductor market: the SOX fell 6.7% and the Nasdaq Composite fell 2.6% in the completed 22 October session.

Source: Reuters via MarketScreener — Source timestamp or bound: published at utc: 2026-10-22T20:03:00Z; updated at utc: 2026-10-22T20:48:00Z; original: 10/23/2026 07:03 am AEDT; modified 07:48 am AEDT Measurement period: October 22 completed US regular session.

The delivery delay and the split between near-term and later earnings estimates support the timing-risk case. The gas-equipment explanation is BofA's assessment, not a confirmed diagnosis from Lam.

Evidence against this view

Check the opposing evidence and other explanations that could weaken this view.

Shows evidence and risks that could challenge this view.

What people say vs the facts

Compare what people say with the observations, without treating attention as proof.

Compares recorded public discussion with checked market facts.

Retrieved: 2026-10-23T08:27:13Z; exact provider update time and sample size unavailable.

They do not prove that the supply problem is fixed or that the rebound will continue. Stocktwits scores are provider indices, not percentages of posts.

Source:

The idea, step by step

Follow the reasoning from the observations to the proposed result. A possible link is not proof.

1. Strong customer demand still needs equipment to be completed and shipped.

2. Missing parts can delay sales even when customers still want the equipment.

3. A nervous market may pay less for those delayed profits.

Research context

Understand the background and earlier comparisons, including the differences that matter.

Completed research synthesis: 2026-10-23T08:49:19.141347Z. Exact one-week deadline: 2026-10-30T08:49:19.141347Z.

Actual website publication is recorded separately and does not restart the horizon. One week allows several sessions for investors to reassess the fresh evidence.

The price call does not assume that longer-term operating projects finish during that week.

Current market focus: AI funding and chip-delivery pressure, energy-security risk, and company earnings that show where cash or margin conversion differs. OTR Database Data was reviewed as bounded background, not used as seven fresh source items.

The key clues

See the main observations behind the idea, with their important qualifications.

Read the matching explanation in Chapter 7 and Chapter 4.

What this means

Read the takeaway and the limits that matter before drawing a conclusion.

Use the nearest legitimately verified recorded observation before or after each fixed deadline, same instrument and currency; earlier wins equal-distance tie. Disclose source and retrieval clock, session, precision, signed gap and incomplete coverage.

Unreliable endpoint UNRESOLVED. No regular-close substitution when a closer supported record exists; no execution claim.

Publication does not restart the horizon.

What’s changing?

Follow the reasoning from the observations to the proposed result. A possible link is not proof.

The new connection is between a specific shipment delay and the different treatment of near-term sales, later earnings and stock valuation. It is not another generic claim that AI spending is risky.

What to check

Read the details behind this part of the research and how they connect to the main idea.

Unreliable endpoint UNRESOLVED.

Evidence, memory & review

Read the details behind this part of the research and how they connect to the main idea.

Read the matching explanation in Chapter 8.

People and organisations

Identify the people, organisations or assets discussed and the part they play in the research.

Lam Research Corporation (LRCX). Lam builds chipmaking equipment.

BofA, Needham and New Street provide separate analyst views; these are opinions, not new customer orders.

OTR reasoning · Why we see this connection

Follow the reasoning from the observations to the proposed result. A possible link is not proof.

1.

2.

3.

Counterpoint · Another possible explanation

Check the opposing evidence and other explanations that could weaken this view.

Read the matching explanation in Chapter 5.

What changed

See what changed in the research and why, while keeping earlier recorded views separate.

Recorded public history

Some Lam shipments could move from the December quarter into the…

This is the first recorded public view. Further public updates will appear here.

We see a delivery problem, not proof that chip demand has disappeared. Some Lam shipments could move from the December quarter into the March quarter because important parts are tight.

Forecast prepared: 23 Oct, 16:59 SGT Published by OTR: 23 Oct 2026, 17:27 SGT

Why the view changed

See what changed in the research and why, while keeping earlier recorded views separate.

Read the matching explanation in Chapter 7.

Evidence, memory & review — 7 linked sources

Check where the information came from, when it was observed and what was verified.

Read the matching explanation in Chapter 7 and Chapter 4.

Keep exploring

Choose how to follow this Signal or compare it with other research.

Read the matching explanation in Chapter 5.

Track this Signal to find it again, compare the evidence, and revisit its recorded outcome.

Explore more Signals →

Evidence, memory & review 12 linked sources

Check where the information came from, when it was observed and what was verified.

Named assets or actors: Lam Research Corporation (LRCX)

Source trail

Any forecast estimate is shown separately with its own source and limitations.

Review status

Check what was reviewed, what remains uncertain and how much the sources can support.

LEARNING REVIEWED WITH DISCLOSED LIMITS

Terms in simple English

Find plain meanings for the specialist terms used in this research.

Watch or on confirmation

The signal asks readers to watch for a stated condition.

Share or equity

A share is a small ownership stake in a company. Its price can rise or fall.

Entry or reference price

A reference quote is not proof that a trade could be made at that price.

Horizon or deadline

The forecast time window. A saved deadline states when the outcome should be checked.

HIT and MISS

MISS means it did not meet those rules. These labels do not measure profit after trading costs.

Estimates whose accuracy has not been established by testing

A judgement that has not been shown to match real outcomes reliably. It is not a proven success rate.

Revenue

Money earned from sales before subtracting costs.

Earnings or net income

A company’s profit after its costs. Earnings reports show how much it made or lost.

Margin in context

A business margin compares revenue with stated costs; it may be a percentage or profit per unit, such as dollars per barrel. For a leveraged trade, margin means money required to support the position. Check the stated measure.

Earnings beat

Earnings above the forecast used for comparison.

Guidance or outlook

Management’s forecast for future sales, profit or other results. It can change.

Valuation

What investors think an asset or company is worth, compared with measures such as sales, profit or cash flow.

Ratio comparing market value with a stated business measure

A comparison of value with profit, sales or another measure. A falling multiple means investors pay less for the same amount of that measure.

Dilution

Existing shareholders owning a smaller share of a company after new shares are issued.

Hundredth of a percentage point (bp or bps)

One hundredth of a percentage point is 0.01 percentage point. A move of 25 hundredths of a percentage point equals 0.25 percentage point.

Percentage point

The gap between two percentages. A rise from 4% to 5% is one percentage point, a 25% rise in the original rate.

Exchange or venue

The market or trading platform supplying a quote. NASDAQ and NYSE are US exchanges; SGX is Singapore Exchange. Prices can differ by venue.

Repricing

Investors changing the price they will pay after new information or changed expectations.

Quarter (Q1 to Q4)

A three-month reporting period. Company financial years can start in different months.

AI or machine learning

Software learning patterns from examples to perform tasks. Its output can be wrong.

Gas-delivery equipment supplies process gases to chipmaking tools. A ratio comparing market value with a stated business measure is the price investors pay for a unit of expected earnings.

A hundredth of a percentage point is one hundredth of a percentage point.

1 / 25
Sources and evidence · 12 sources

Check the original reports and the limits of this research.

  1. Reference sourcestockanalysis.com · Used throughout this Signal
  2. www.marketscreener.com ↗marketscreener.com · Used throughout this Signal
  3. www.benzinga.com ↗benzinga.com · Used throughout this Signal
  4. www.marketscreener.com ↗marketscreener.com · Used throughout this Signal
  5. www.investing.com ↗investing.com · Used throughout this Signal
  6. www.marketscreener.com ↗marketscreener.com · Used throughout this Signal
  7. ca.investing.com ↗ca.investing.com · Used throughout this Signal
  8. www.marketscreener.com ↗marketscreener.com · Used throughout this Signal
  9. www.marketscreener.com ↗marketscreener.com · Used throughout this Signal
  10. www.marketbeat.com ↗marketbeat.com · Used throughout this Signal
  11. au.marketscreener.com ↗au.marketscreener.com · Used throughout this Signal
  12. stocktwits.com ↗stocktwits.com · What people say vs the facts; What changed; Evidence, memory & review 12 linked sources
Detailed source notes
  • Reference source

    Investment call details are available with membership.

  • www.marketscreener.com ↗

    Used in: Evidence behind this view; The key clues; Sources and verification; Source trail; Evidence, memory & review — 7 linked sources; Original research record; What changed; Evidence, memory & review 12 linked sources.

  • www.benzinga.com ↗

    Used in: Evidence behind this view; The key clues; Sources and verification; Source trail; Evidence, memory & review — 7 linked sources; Original research record; What changed; Evidence, memory & review 12 linked sources.

  • www.marketscreener.com ↗

    Used in: Evidence behind this view; The key clues; Sources and verification; Source trail; Evidence, memory & review — 7 linked sources; Original research record; What changed; Evidence, memory & review 12 linked sources.

  • www.investing.com ↗

    Used in: Evidence behind this view; The key clues; Sources and verification; Source trail; Evidence, memory & review — 7 linked sources; Original research record; What changed; Evidence, memory & review 12 linked sources.

  • www.marketscreener.com ↗

    Used in: Evidence behind this view; The key clues; Sources and verification; Source trail; Evidence, memory & review — 7 linked sources; Original research record; What changed; Evidence, memory & review 12 linked sources.

  • ca.investing.com ↗

    Used in: Evidence behind this view; The key clues; Sources and verification; Source trail; Evidence, memory & review — 7 linked sources; Original research record; What changed; Evidence, memory & review 12 linked sources.

  • www.marketscreener.com ↗

    Used in: Evidence behind this view; The key clues; Sources and verification; Source trail; Evidence, memory & review — 7 linked sources; Original research record; What changed; Evidence, memory & review 12 linked sources.

  • www.marketscreener.com ↗

    Used in: Evidence behind this view; The key clues; Sources and verification; Source trail; Evidence, memory & review — 7 linked sources; Original research record; What changed; Evidence, memory & review 12 linked sources.

  • www.marketbeat.com ↗

    Used in: Evidence behind this view; The key clues; Sources and verification; Source trail; Evidence, memory & review — 7 linked sources; Original research record; What changed; Evidence, memory & review 12 linked sources.

  • au.marketscreener.com ↗

    Used in: Evidence behind this view; The key clues; Sources and verification; Source trail; Evidence, memory & review — 7 linked sources; Original research record; What changed; Evidence, memory & review 12 linked sources.

  • stocktwits.com ↗

    Used in: What people say vs the facts; Source trail; Original research record; What changed; Evidence, memory & review 12 linked sources.

Lam Research Corporation (LRCX) 1 week

Investment call details are available with membership.

Investment call details are available with membership.

Investment call details are available with membership.

  • Investment call details are available with membership.
  • Investment call details are available with membership.

PENDING PRICE UNVERIFIED Historical record

  • Author-submitted research. The underlying facts and market prices have not been independently verified.
  • Seven numbered evidence/link pairs, not seven independent corporate events. Preserve source-access limitations, event bounds and measurement periods.
  • Evidence 1: We see a fresh market report identify supply-chain constraints as a limit on fiscal Q2 sales, even after adjusted earnings and revenue beat expectations.
  • Source: MT Newswires via MarketScreener — Source timestamp or bound: published at utc: 2026-10-22T09:33:00Z; original: 10/22/2026 05:33 am EDT Measurement period: Fiscal quarter ended September 27, 2026; December-quarter guidance; earnings call October 21, 2026.
  • Verification and access limits: Exact EDT publication time verified on the public MT Newswires headline page. Public headline and exact publication timestamp only; body paywalled.
  • Detailed analytical claims remain supported separately by the opened full article. Supporting detail:
  • Investment call details are available with membership.
  • Source: MT Newswires via MarketScreener — Source timestamp or bound: published at utc: 2026-10-22T13:01:00Z; original: 10/22/2026 09:01 am EDT Measurement period: Analyst action October 22; calendar 2027/2028 estimates.
  • Investment call details are available with membership.
  • Source: MT Newswires via MarketScreener — Source timestamp or bound: published at utc: 2026-10-22T12:52:00Z; original: 10/22/2026 08:52 am EDT Measurement period: October 22 analyst revision; next-quarter versus calendar 2028 estimates.
  • Evidence 4: We see the repricing spreading beyond one analyst: New Street Research lowered its target to $255 from $285.
  • Source: MT Newswires via MarketScreener — Source timestamp or bound: published at utc: 2026-10-22T16:11:00Z; original: 10/22/2026 12:11 pm EDT Measurement period: October 22 analyst action.
  • Verification and access limits: Public title and timestamp opened; body paywalled. No claim from unseen body.
  • Evidence 5: We see pressure from the customers' funding model: Meta's capital-spending needs and new non-voting share class brought attention to equity funding and dilution across the AI trade.
  • Source: Reuters via MarketScreener — Source timestamp or bound: published at utc: 2026-10-22T18:57:00Z; updated at utc: 2026-10-22T20:35:00Z; original: 10/22/2026 02:57 pm EDT; modified 04:35 pm EDT Measurement period: October 22 market reaction; Meta's prior-day results and future funding plans.
  • Verification and access limits: Full article opened.
  • Evidence 6: We see a large completed price adjustment: LRCX closed at $230.15, down 11.76%, on 22 October. This reaction may already reflect much of the bad news.
  • Source: MarketBeat quote data — Source timestamp or bound: measurement as of utc: 2026-10-22T20:00:00Z; original: Closing price 10/22/2026 04:00 PM Eastern Measurement period: 22 October Nasdaq regular session. Verification and access limits: Full quote opened; close cross-checked with MarketScreener.
  • Evidence 7: We see the selloff reach the wider semiconductor market: the SOX fell 6.7% and the Nasdaq Composite fell 2.6% in the completed 22 October session. This means the Lam move was not purely company-specific.
  • Source: Reuters via MarketScreener — Source timestamp or bound: published at utc: 2026-10-22T20:03:00Z; updated at utc: 2026-10-22T20:48:00Z; original: 10/23/2026 07:03 am AEDT; modified 07:48 am AEDT Measurement period: October 22 completed US regular session.
  • 1. 2. 3. 4. 5. 6. 7.
  • Supplemental sources:
  • Investment call details are available with membership.
  • Retrieved: 2026-10-23T08:27:13Z; exact provider update time and sample size unavailable.
  • Investment call details are available with membership.
  • They do not prove that the supply problem is fixed or that the rebound will continue. Stocktwits scores are provider indices, not percentages of posts.
  • Investment call details are available with membership.
  • Investment call details are available with membership.
  • Source:
  • Investment call details are available with membership.
  • OnTheRice’s Emerging Data We see a delivery problem, not proof that chip demand has disappeared. Some Lam shipments could move from the December quarter into the March quarter because important parts are tight.
  • Analysts are keeping much of their longer-term earnings outlook while lowering near-term estimates or valuations.
  • The idea, step by step 1. Strong customer demand still needs equipment to be completed and shipped.
  • 2. Missing parts can delay sales even when customers still want the equipment.
  • 3. A nervous market may pay less for those delayed profits.
  • Investment call details are available with membership.
  • Research context Completed research synthesis: 2026-10-23T08:49:19.141347Z. Exact one-week deadline: 2026-10-30T08:49:19.141347Z.
  • Actual website publication is recorded separately and does not restart the horizon. One week allows several sessions for investors to reassess the fresh evidence.
  • The price call does not assume that longer-term operating projects finish during that week.
  • Instrument: Lam Research Corporation common stock, Nasdaq: LRCX, USD.
  • Venue: Nasdaq; session: US premarket. Precision: Minute; serialized :00 does not assert a seconds-level trade time.
  • Recorded premarket reference, not a live executable offer. The observation precedes retrieval; retain both clocks.
  • Current market focus: AI funding and chip-delivery pressure, energy-security risk, and company earnings that show where cash or margin conversion differs. OTR Database Data was reviewed as bounded background, not used as seven fresh source items.
  • The key clues Evidence 1: We see a fresh market report identify supply-chain constraints as a limit on fiscal Q2 sales, even after adjusted earnings and revenue beat expectations.
  • What could change this view? Watch for confirmed improvement in component supply and shipment timing.
  • The eventual delivery of equipment is a separate business test, not something expected to finish within this one-week call.
  • Confidence: 55%, subjective and uncalibrated.
  • Base research confidence: 57%; social counterweight: -2 percentage points; final confidence: 55%. This is editorial judgment, not measured accuracy or social-post share.
  • Use the nearest legitimately verified recorded observation before or after each fixed deadline, same instrument and currency; earlier wins equal-distance tie. Disclose source and retrieval clock, session, precision, signed gap and incomplete coverage.
  • Investment call details are available with membership.
  • Unreliable endpoint UNRESOLVED. No regular-close substitution when a closer supported record exists; no execution claim.
  • Publication does not restart the horizon.
  • Evidence behind this view The delivery delay and the split between near-term and later earnings estimates support the timing-risk case. The gas-equipment explanation is BofA's assessment, not a confirmed diagnosis from Lam.
  • Evidence against this view Demand remains strong and the shortage may be temporary. BofA increased its later earnings estimates.
  • The stock already fell sharply and then rebounded before the next session; optimistic social sentiment also warns against assuming selling must continue.
  • Investment call details are available with membership.
  • Sources and verification Seven numbered evidence/link pairs, not seven independent corporate events. Preserve source-access limitations, event bounds and measurement periods.
  • What’s changing? The new connection is between a specific shipment delay and the different treatment of near-term sales, later earnings and stock valuation.
  • It is not another generic claim that AI spending is risky.
  • What to check Watch for confirmed improvement in component supply and shipment timing.
  • The eventual delivery of equipment is a separate business test, not something expected to finish within this one-week call.
  • Evidence, memory & review OTR Database Data already covered AI funding pressure and chip-sector weakness. This call uses new shipment and analyst evidence to test a more specific mechanism.
  • No verified comparable historical success rate is available.
  • People and organisations Lam Research Corporation (LRCX). Lam builds chipmaking equipment.
  • BofA, Needham and New Street provide separate analyst views; these are opinions, not new customer orders.
  • OTR reasoning We see a delivery problem, not proof that chip demand has disappeared. Some Lam shipments could move from the December quarter into the March quarter because important parts are tight.
  • Counterpoint Demand remains strong and the shortage may be temporary. BofA increased its later earnings estimates.
  • Source trail 1. 2. 3. 4. 5. 6. 7.
  • What changed The new connection is between a specific shipment delay and the different treatment of near-term sales, later earnings and stock valuation. It is not another generic claim that AI spending is risky.
  • Why the view changed The delivery delay and the split between near-term and later earnings estimates support the timing-risk case. The gas-equipment explanation is BofA's assessment, not a confirmed diagnosis from Lam.
  • Evidence, memory & review — 7 linked sources Evidence 1: We see a fresh market report identify supply-chain constraints as a limit on fiscal Q2 sales, even after adjusted earnings and revenue beat expectations.
  • Keep exploring Watch for confirmed improvement in component supply and shipment timing.
  • Terms in simple English Gas-delivery equipment supplies process gases to chipmaking tools. A valuation multiple is the price investors pay for a unit of expected earnings.
  • A basis point is one hundredth of a percentage point.
  • Investment call details are available with membership.

Investment call details are available with membership.

  • Edition prepared 23 Oct 2026, 16:59:57 SGT. Native first-publication time is recorded separately.

1 week

Investment call details are available with membership.

  • Instrument: Lam Research Corporation common stock, Nasdaq: LRCX, USD.
  • Source: · AUTHOR_SUPPLIED_REFERENCE_NOT_VERIFIED_PUBLICATION_PRICE Source bar: Publication time unverified–Publication time unverified · retrieved Publication time unverified Not an exact issue-time trade; custom outcome check is manual.

Native first-publication time is not yet recorded.

  • Investment call details are available with membership.
  • This call has a frozen source-specific threshold and completed-bar rule. The generic sign-only ledger is disabled; a source-linked manual resolution is required.
  • Source: · Lam Research Corporation common stock, Nasdaq: LRCX, USD · Nasdaq · Session not supplied session.
  • The source labels a completed one-minute close at 23 Oct 2026, 16:10:00 SGT; bar interval Publication time unverified–Publication time unverified, retrieved Publication time unverified. This is a vendor reference, not an individual trade at the issue instant.
  • Frozen resolution rule: Original source issue and one-week deadline remain unchanged by website publication or consolidation.
  • Scoring state: Manual evidence required. The generic sign-only ledger is disabled for this call.
  • A reference is the saved starting quote. An endpoint is the comparison quote used for the result.
  • A venue is the market or platform supplying that quote. A snapshot is a saved copy of the evidence at a stated time.
  • A one-minute price bar groups prices recorded within one minute; its close is the last price in that group. It does not prove a trade happened at the exact forecast time.
  • A vendor is the data provider, and an execution price is the price of an actual trade.
  • Sign-only scoring checks whether the price rose or fell. A custom rule uses the separate saved conditions shown with that call.
  • Supplied or owner-recorded evidence retains its stated limits; it is not automatically an independent check.